INFINITRAK

InfiniTrak’s Executive leadership team brings expertise in biotechnology supply chain management, Information Technology, and regulatory compliance. We’ve followed the developments of the Drug Supply Chain Security Act (DSCSA) while participating in FDA workshops as the law began its rollout, and are well-versed in its nuances and complexities. InfiniTrak was created from a strong desire to bring a solution to market that supports small businesses, caters to pharmacists needs, and ultimatel... y helps protect the pharmaceutical supply chain from counterfeiting and theft. Because dispensaries are the last line of defense in the publics’ exposure to drugs, InfiniTrak targets its work to secure the supply chain at the dispensary level. Our expertise in both technology and the supply chain market allowed us to create a Track and Trace software product that provides greater control and compliance protection and allows users to manage data and generate DSCSA-required reports. Our product, is cloud-based and uses the Software-as-a-Service (SaaS) model to drive cost effectiveness. Additionally, the cloud enables stakeholders in the pharmaceutical, medical device or biotech/medtech industry as a whole to comply with complex track and trace laws using a central repository for their system of record.  InfiniTrak serves as a trusted third-party solution with point-to-point tracking of pharmaceutical products within supply chain as product(s) change ownership. InfiniTrak produces the relevant transaction data and documentation to hand-off to the next owner in the chain of custody and stores the data in the cloud database for the 6 year required retention time.  InfiniTrak was designed for retail and hospital pharmacies to keep the user interface simple yet maintain the necessary, full-range features for compliance with new FDA law: Drug Supply Chain Security Act (DSCSA).  The software was crowd-sourced enhancements will drive new functionality to address changing needs to this market segment and continues to expand to new segments of the supply chain as well as expand to new market sectors in the healthcare industry.More